Further information

Max Planck Seminar

12903 1518107510

Jeffrey Rathmell – Fueling T cells in inflammation and immunity

  • Date: Feb 23, 2018
  • Time: 13:00 - 14:00
  • Speaker: Jeffrey Rathmell
  • Vanderbilt University, Nashville, USA
  • Location: MPI-IE
  • Room: Main Lecture Hall
  • Host: Erika Pearce
Jeffrey Rathmell is Professor at the Vanderbilt University (Nashville, USA) and visits the MPI-IE Freiburg this February. The Rathmell lab focuses on how metabolic pathways influence the function and fate of lymphocytes in inflammatory diseases, anti-tumor immunity, and in leukemia. Hosted by Erika Pearce, his seminar is entitled “Fueling T cells in inflammation and immunity”. Start is on Friday, February 23, 2018 at 1pm. (http://www.ie-freiburg.mpg.de/events/12903/4678708)

Dr. Rathmell studies mechanisms by which extracellular cues influence lymphocyte death and differentiation in efforts to control inflammatory diseases and leukemia. Following undergraduate studies on Biology at the University of Northern Iowa, his earned a PhD in Immunology on B cell tolerance and death mechanisms at Stanford University. In postdoctoral studies at the University of Chicago and University of Pennsylvania, he showed that lymphocyte metabolism was dynamically regulated by growth factors and controls apoptotic mechanisms. He began at Duke University in 2003 in the departments of Pharmacology and Cancer Biology and Immunology, as well as a member of the Duke Molecular Physiology Institute. Dr. Rathmell's group showed that the metabolism of T cells is highly dynamic and that specific metabolic programs are essential for each functional T cell subsets. These fundamental metabolic distinctions may now allow modulation of selective populations of lymphocytes in inflammatory diseases and anti-tumor immunity. He joined the faculty of Vanderbilt University in 2015 as Professor of Pathology, Microbiology, and Immunology to direct the Vanderbilt Center for Immunobiology and co-lead the Vanderbilt Ingram Cancer Center Host Tumor Interactions Program and now is Associate Director of the Vanderbilt Institute of Infection, Immunology, and Inflammation and co-leader of the Molecular Pathology and Immunology PhD training program.

source: vumc


 
Go to Editor View
loading content